Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares for the month of August 2025. The filing details a share repurchase executed on August 13, 2025, pursuant to a non-discretionary agreement with Merrill Lynch International entered into on June 4, 2025.
Key Financial Metrics and Transaction Details
The filing focuses exclusively on capital allocation via share buybacks rather than operational financial performance. Key metrics for the reported transaction include:
- Shares Purchased: 306,478 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,411.50p; highest price paid was 1,434.50p.
- Average Price: Volume-weighted average price paid was 1,424.64p.
- Trading Venue: All transactions occurred on the London Stock Exchange (XLON).
- Treasury Holdings: Following this purchase, the Company holds 241,339,099 ordinary shares in treasury.
- Shares in Issue: 4,074,052,147 ordinary shares (excluding Treasury shares).
- Voting Rights: Treasury shares represent 5.92% of total voting rights.
The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Program Progress
Since the commencement of the current buyback program on June 4, 2025, the Company has purchased an aggregate of 23,204,716 ordinary shares. The August 13 transaction represents a continuation of this existing program. There are no material changes to the Company's business operations or financial condition disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains a standard cautionary statement regarding forward-looking statements. GSK notes that projections are subject to risks and uncertainties that may cause actual results to differ materially. Specific risk factors are referenced in the Company's Annual Report on Form 20-F for 2024 and Q2 Results for 2025. No new guidance or management commentary regarding future financial performance is provided in this document.
Investor Verification Checklist
- Verify the total cumulative buyback volume since June 4, 2025 (23,204,716 shares).
- Confirm the current percentage of voting rights held in treasury (5.92%).
- Review the non-discretionary agreement terms with Merrill Lynch International to understand remaining program capacity.
- Consult the referenced Form 20-F (2024) and Q2 2025 results for comprehensive financial data not included in this 6-K.